These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15813973)

  • 1. Sildenafil citrate increases myocardial cGMP content in rat heart, decreases its hypertrophic response to isoproterenol and decreases myocardial leak of creatine kinase and troponin T.
    Hassan MA; Ketat AF
    BMC Pharmacol; 2005 Apr; 5():10. PubMed ID: 15813973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism.
    Takimoto E; Champion HC; Belardi D; Moslehi J; Mongillo M; Mergia E; Montrose DC; Isoda T; Aufiero K; Zaccolo M; Dostmann WR; Smith CJ; Kass DA
    Circ Res; 2005 Jan; 96(1):100-9. PubMed ID: 15576651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sildenafil reduces L-NAME-induced severe hypertension and worsening of myocardial ischaemia-reperfusion damage in the rat.
    Rossoni G; Manfredi B; De Gennaro Colonna V; Berti M; Guazzi M; Berti F
    Br J Pharmacol; 2007 Mar; 150(5):567-76. PubMed ID: 17245365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the NO/cGMP/K(ATP) pathway in the protective effects of sildenafil against ethanol-induced gastric damage in rats.
    Medeiros JV; Gadelha GG; Lima SJ; Garcia JA; Soares PM; Santos AA; Brito GA; Ribeiro RA; Souza MH
    Br J Pharmacol; 2008 Feb; 153(4):721-7. PubMed ID: 18071300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
    Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
    Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased cyclic guanosine monophosphate production and endothelial nitric oxide synthase level in mononuclear cells from sildenafil citrate-treated patients with erectile dysfunction.
    García-Cardoso J; Vela R; Mahillo E; Mateos-Cáceres PJ; Modrego J; Macaya C; López-Farré AJ
    Int J Impot Res; 2010; 22(1):68-76. PubMed ID: 19907424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does sildenafil cause myocardial infarction or sudden cardiac death?
    Kontaras K; Varnavas V; Kyriakides ZS
    Am J Cardiovasc Drugs; 2008; 8(1):1-7. PubMed ID: 18303932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice.
    Das A; Salloum FN; Xi L; Rao YJ; Kukreja RC
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1236-43. PubMed ID: 19286961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures.
    Valente EG; Vernet D; Ferrini MG; Qian A; Rajfer J; Gonzalez-Cadavid NF
    Nitric Oxide; 2003 Dec; 9(4):229-44. PubMed ID: 14996430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic inhibition of nitric-oxide synthase induces hypertension and erectile dysfunction in the rat that is not reversed by sildenafil.
    Gur S; Kadowitz PJ; Gurkan L; Chandra S; Dewitt SY; Harbin A; Sikka SC; Agrawal KC; Hellstrom WJ
    BJU Int; 2010 Jul; 106(1):78-83. PubMed ID: 20002674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats.
    Ferreira-Melo SE; Yugar-Toledo JC; Coelho OR; De Luca IM; Tanus-Santos JE; Hyslop S; Irigoyen MC; Moreno H
    Eur J Pharmacol; 2006 Aug; 542(1-3):141-7. PubMed ID: 16806160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained soluble guanylate cyclase stimulation offsets nitric-oxide synthase inhibition to restore acute cardiac modulation by sildenafil.
    Nagayama T; Zhang M; Hsu S; Takimoto E; Kass DA
    J Pharmacol Exp Ther; 2008 Aug; 326(2):380-7. PubMed ID: 18456872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of cGMP-dependent protein kinase I (cGKI) and PDE5 in the regulation of Ang II-induced cardiac hypertrophy and fibrosis.
    Patrucco E; Domes K; Sbroggió M; Blaich A; Schlossmann J; Desch M; Rybalkin SD; Beavo JA; Lukowski R; Hofmann F
    Proc Natl Acad Sci U S A; 2014 Sep; 111(35):12925-9. PubMed ID: 25139994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maximizing the renal cyclic 3'-5'-guanosine monophosphate system with type V phosphodiesterase inhibition and exogenous natriuretic peptide: a novel strategy to improve renal function in experimental overt heart failure.
    Chen HH; Huntley BK; Schirger JA; Cataliotti A; Burnett JC
    J Am Soc Nephrol; 2006 Oct; 17(10):2742-7. PubMed ID: 16928803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphodiesterase inhibition by sildenafil citrate attenuates a maze learning impairment in rats induced by nitric oxide synthase inhibition.
    Devan BD; Bowker JL; Duffy KB; Bharati IS; Jimenez M; Sierra-Mercado D; Nelson CM; Spangler EL; Ingram DK
    Psychopharmacology (Berl); 2006 Jan; 183(4):439-45. PubMed ID: 16320087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sildenafil increases the force of right atrial contractions in vitro via the NO-guanylyl cyclase pathway involving β-adrenoceptor linked mechanisms.
    Kanoo S; Deshpande SB
    Pharmacol Rep; 2009; 61(6):1146-52. PubMed ID: 20081250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proconvulsant effect of sildenafil in mice: role of nitric oxide-cGMP pathway.
    Riazi K; Roshanpour M; Rafiei-Tabatabaei N; Homayoun H; Ebrahimi F; Dehpour AR
    Br J Pharmacol; 2006 Apr; 147(8):935-43. PubMed ID: 16474413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphodiesterase-5 inhibition by sildenafil citrate in a rat model of bleomycin-induced lung fibrosis.
    Yildirim A; Ersoy Y; Ercan F; Atukeren P; Gumustas K; Uslu U; Alican I
    Pulm Pharmacol Ther; 2010 Jun; 23(3):215-21. PubMed ID: 19945540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sildenafil inhibits hypoxia-induced pulmonary hypertension.
    Zhao L; Mason NA; Morrell NW; Kojonazarov B; Sadykov A; Maripov A; Mirrakhimov MM; Aldashev A; Wilkins MR
    Circulation; 2001 Jul; 104(4):424-8. PubMed ID: 11468204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy.
    Takimoto E; Champion HC; Li M; Belardi D; Ren S; Rodriguez ER; Bedja D; Gabrielson KL; Wang Y; Kass DA
    Nat Med; 2005 Feb; 11(2):214-22. PubMed ID: 15665834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.